NYSE: DHR
Danaher Corp Earnings & Revenue

DHR past earnings growth

How has DHR's earnings growth performed historically?
Company
47.51%
Industry
18.24%
Market
82.89%
DHR's earnings have grown slower (1.07% per year) than the US Diagnostics & Research industry average (12.63%)
Performance
DHR's earnings have grown slower (1.07% per year) than the US market average (77.34%)
Performance
DHR's earnings growth is accelerating - its growth over the last year (47.51%) is above its 5-year compound annual rate (1.07%)
Performance

DHR past revenue growth

How has DHR's revenue growth performed historically?
Company
17.99%
Industry
25.1%
Market
16.55%
DHR's revenue has grown slower (8.69% per year) than the US Diagnostics & Research industry average (16.33%)
Performance
DHR's revenue has grown slower (8.69% per year) than the US market average (15.67%)
Performance
DHR's revenue growth is accelerating - its growth over the last year (17.99%) is above its 5-year compound annual rate (8.69%)
Performance

DHR earnings and revenue history

Current Revenue
$18.4B
Current Earnings
$3.6B
Current Profit Margin
19.4%
DHR's has demonstrated consistent long-term earnings growth over the past 10 years (107%)
Performance

DHR Return on equity

Current Company
10.5%
Current Industry
31.5%
Current Market
13.3%
DHR's Return on Equity (10.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

DHR Return on assets

Current Company
5.2%
Current Industry
6%
Current Market
7.1%
DHR is generating lower Return on Assets (5.2%) than the US Diagnostics & Research industry average (5.36%)
Performance

DHR Return on capital employed

Current Company
6.91%
Current Industry
14.5%
DHR has gotten more efficient at generating Return on Capital (6.91%) compared to 3 years ago (6.83%)
Performance

Danaher Corp Earnings & Revenue FAQ

On May 06, 2020, Danaher Corp (NYSE: DHR) reported Q1 2020 earnings per share (EPS) of $0.83, up 80.43% year over year. Total Danaher Corp earnings for the quarter were $575.50 million. In the same quarter last year, Danaher Corp's earnings per share (EPS) was $0.46.
On May 06, 2020, Danaher Corp (NYSE: DHR) reported Q1 2020 revenue of $4.34 billion up 2.91% year over year. In the same quarter last year, Danaher Corp's revenue was $4.22 billion.
As of Q4 2020, Danaher Corp's earnings has grown 47.51% year over year. This is 29.26 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 18.24%. Danaher Corp's earnings in the past year totalled $3.57 billion.
As of Q4 2020, Danaher Corp's revenue has grown 17.99% year over year. This is 7.11 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 25.1%. Danaher Corp's revenue in the past year totalled $18.36 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics